Monash IVF's rising share price

Monash IVF's share price has risen 33% since its annual result and it's time for a downgrade.

It's been a bumpy few months for shareholders of assisted reproduction provider Monash IVF, which was hit by a labour dispute and increasing competition from low-cost IVF models, including Primary Health Care’s new bulk-billing clinics. Nonetheless, as we explained in Monash IVF: Result 2015 on 28 Aug 15 (Buy – $1.12), it was reassuring to see that the company was still able to increase prices by 3% over the year. 

The stock has risen 33% in the two months since the result, which puts it above our $1.40 Buy price so we’re downgrading to HOLD.

Note: Our Growth Portfolio and Income Portfolio own shares in Monash IVF.

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles